These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Lenz G; Davis RE; Ngo VN; Lam L; George TC; Wright GW; Dave SS; Zhao H; Xu W; Rosenwald A; Ott G; Muller-Hermelink HK; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Fisher RI; Chan WC; Staudt LM Science; 2008 Mar; 319(5870):1676-9. PubMed ID: 18323416 [TBL] [Abstract][Full Text] [Related]
4. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Davis RE; Ngo VN; Lenz G; Tolar P; Young RM; Romesser PB; Kohlhammer H; Lamy L; Zhao H; Yang Y; Xu W; Shaffer AL; Wright G; Xiao W; Powell J; Jiang JK; Thomas CJ; Rosenwald A; Ott G; Muller-Hermelink HK; Gascoyne RD; Connors JM; Johnson NA; Rimsza LM; Campo E; Jaffe ES; Wilson WH; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Pierce SK; Staudt LM Nature; 2010 Jan; 463(7277):88-92. PubMed ID: 20054396 [TBL] [Abstract][Full Text] [Related]
5. Gain-of-function mutations in CARD11 promote enhanced aggregation and idiosyncratic signalosome assembly. Stinson JR; Dorjbal B; McDaniel DP; David L; Wu H; Snow AL Cell Immunol; 2020 Jul; 353():104129. PubMed ID: 32473470 [TBL] [Abstract][Full Text] [Related]
6. Role of nuclear factor-κB regulators TNFAIP3 and CARD11 in Middle Eastern diffuse large B-cell lymphoma. Bu R; Bavi P; Abubaker J; Jehan Z; Al-Haqawi W; Ajarim D; Al-Dayel F; Uddin S; Al-Kuraya KS Leuk Lymphoma; 2012 Oct; 53(10):1971-7. PubMed ID: 22397314 [TBL] [Abstract][Full Text] [Related]
7. Cooperative Control of Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling by an Unusual Array of Redundant Repressive Elements. Jattani RP; Tritapoe JM; Pomerantz JL J Biol Chem; 2016 Apr; 291(16):8324-36. PubMed ID: 26884335 [TBL] [Abstract][Full Text] [Related]
8. MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma. Aggarwal V; Das A; Bal A; Srinivasan R; Das R; Prakash G; Malhotra P; Varma S Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):311-318. PubMed ID: 29734251 [TBL] [Abstract][Full Text] [Related]
10. [Expression and prognostic value of CARD11 in diffuse large B cell lymphoma]. Zhao D; Li D; Zhong D; Zhang W Zhonghua Xue Ye Xue Za Zhi; 2016 Jan; 37(1):30-4. PubMed ID: 26876250 [TBL] [Abstract][Full Text] [Related]
11. Synergistic activity of Card11 mutant and Bcl6 in the development of diffuse large B-cell lymphoma in a mouse model. Takahara T; Matsuo K; Seto M; Nakamura S; Tsuzuki S Cancer Sci; 2016 Nov; 107(11):1572-1580. PubMed ID: 27560392 [TBL] [Abstract][Full Text] [Related]
12. Combinatorial BTK and MALT1 inhibition augments killing of CD79 mutant diffuse large B cell lymphoma. Nagel D; Bognar M; Eitelhuber AC; Kutzner K; Vincendeau M; Krappmann D Oncotarget; 2015 Dec; 6(39):42232-42. PubMed ID: 26540570 [TBL] [Abstract][Full Text] [Related]
13. Intramolecular Interactions and Regulation of Cofactor Binding by the Four Repressive Elements in the Caspase Recruitment Domain-containing Protein 11 (CARD11) Inhibitory Domain. Jattani RP; Tritapoe JM; Pomerantz JL J Biol Chem; 2016 Apr; 291(16):8338-48. PubMed ID: 26884334 [TBL] [Abstract][Full Text] [Related]
14. MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma. Takeuchi T; Yamaguchi M; Kobayashi K; Miyazaki K; Tawara I; Imai H; Ono R; Nosaka T; Tanaka K; Katayama N Cancer; 2017 Apr; 123(7):1166-1173. PubMed ID: 27915469 [TBL] [Abstract][Full Text] [Related]
15. Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas. Bognar MK; Vincendeau M; Erdmann T; Seeholzer T; Grau M; Linnemann JR; Ruland J; Scheel CH; Lenz P; Ott G; Lenz G; Hauck SM; Krappmann D Oncogene; 2016 Aug; 35(32):4269-81. PubMed ID: 26776161 [TBL] [Abstract][Full Text] [Related]